SCHEMBL13200380

SCHEMBL13200380

CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3nc(N)nc4[nH]cnc34)cc2)no1

nearest known ligand 0.63

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 14/20 0.63
▸ NTRK1 P04629 2/20 0.56
▸ EGFR P00533 2/20 0.53
▸ AURKA O14965 1/20 0.53
▸ MAP4K4 O95819 1/20 0.53
▸ CSF1R P07333 1/20 0.53
▸ AURKB Q96GD4 1/20 0.53
▸ FLT3 P36888 1/20 0.49
▸ ROCK1 Q13464 1/20 0.46
▸ KDR P35968 1/20 0.44
▸ NTRK3 Q16288 1/20 0.42
▸ NTRK2 Q16620 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13200212 0.90 RET (0.61) RETNTRK1EGFRAURKAMAP4K4
SCHEMBL13200210 0.88 RET (0.74) RETNTRK1EGFRAURKAMAP4K4
SCHEMBL13234896 0.87 NTRK1 (0.54) RETNTRK1CSF1RAURKBFLT3
SCHEMBL9978507 0.77 FLT3 (0.62) RETNTRK1EGFRAURKAMAP4K4
SCHEMBL13234895 0.76 NTRK1 (0.54) RETNTRK1CSF1RAURKBFLT3
SCHEMBL13200317 0.75 RET (0.58) RETNTRK1EGFRAURKAMAP4K4
SCHEMBL13234898 0.75 NTRK1 (0.64) RETNTRK1CSF1RAURKBFLT3
SCHEMBL1256784 0.73 RET (0.63) RETNTRK1EGFRAURKAMAP4K4
SCHEMBL13200780 0.72 FLT3 (0.63) RETNTRK1EGFRCSF1RFLT3
SCHEMBL13199933 0.72 GAPDH (0.71) RETNTRK1EGFRFLT3ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767670-B2 Substituted 3-carboxamido isoxazoles as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-08-03 — — US disclosed
US-7767670-B2 Substituted 3-carboxamido isoxazoles as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-08-03 — — US disclosed
Send feedback